Diligence memo · auto-generated · as of July 3, 2026
Clozex Medical, Inc.
Clozex Medical, Inc. looks under-valued against its niche peers and is at-risk on financing cadence.
Businessfiled
Clozex Medical, Inc. operates in Healthtech, based in W. BRIDGEWATER.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Clozex Medical, Inc. has raised $10M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $4.5M on 2018-10-16.
Most recent recorded round closed around 2023-11-01.
Valuation (modeled)modeled
Provath models Clozex Medical, Inc. at approximately $19M (range $3.8M–$49M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.46× the median modeled value of Series A Healthtech companies in 2022–2024 (190 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 20 months.
Last raise 2.7 yr ago; this sector typically re-raises about every 14 months.
Past due for a raise versus sector cadence — watch for distress or a bridge.
The last round stepped up 1.0× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 70% of Healthtech peers (2138 compared).
Modeled value ranks above 44% of those peers.
Closest niche peers: Nayya Health, Inc., Nue Life Health Inc., W Health Studio, Inc., Avant-garde Health, Inc., Kinetik Healthcare Solutions, Inc.
Peoplefiled
16 named people on file across officers, directors and signatories.
Risks & flagsmixed
Overdue for a raise versus sector norm — distress or bridge risk.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.